top of page
Image by National Cancer Institute

Pipeline

GTS currently offers a diverse range of cutting-edge oncology and autoimmune therapeutics crafted from nature's pharmacy. Nature has done the innovation; we have identified the biologically active compounds most viable to have therapeutic value. Each of our products represents a breakthrough in cancer treatment: 

CTB-1

Our flagship product, CTB-1 is a groundbreaking compound primarily derived from cinnamon bark but can be found in other natural sources. It has been clinically proven to exhibit remarkable anti-cancer properties, selectively targeting malignant cells while also minimizing harm to healthy tissues. CTB-1 opens new avenues for treating various types of cancer with enhanced precision. 

CTD-1

Another natural compound found from cinnamon bark that has proven clinical anti-cancer and autoimmune therapy properties. This versatile compound reinforces the body's natural defense mechanisms, bolstering the immune system and aiding in the fight against cancer and inflammatory conditions.

Need more details? Contact us

We are happy to answer your questions. Contact us by phone, email or via our social media channels.

© 2024 GTS Biotech, LLC

  • X
  • LinkedIn
bottom of page